Impact of haemoglobin concentration and chronic kidney disease in patients with coronary heart disease undergoing percutaneous coronary interventions

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2563-2570

  Husemann, Wibke ^a   Fobker, Manfred ^a   Pohlen, Michele ^a   Bruch, Christian ^a   Hausberg, Martin ^a   Breithardt, Günter ^a   Reinecke, Holger ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE   (Germany)

Author keywords

Anaemia; Angioplasty; Mortality; PCI; Renal function

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

AGED; ANEMIA; ANGIOGRAPHY; CARDIOVASCULAR SURGICAL PROCEDURES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548435261     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm206     Document Type: Article

References (24)

1. Silverberg DS, Iaina A, Wexler D. The pathological consequences of anaemia. Clin Lab Haematol 2001; 23: 1-6
2. Spivak JL. The blood in systemic disorders. Lancet 2000; 355: 1707-1712
3. Silverberg DS, Wexler D, Sheps D. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780
4. Reinecke H, Breithardt G. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2005; 111: E263-e264
5. Sarnak MJ, Tighiouart H, Manjunath G. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27-33
6. Reinecke H, Trey T, Wellmann J et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003; 24: 2142-2150
7. Mc Kechnie RS, Smith D, Montoye C. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004; 110: 271-277
8. Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004; 44: 541-546
9. Go AS, Chertow GM, Fan D. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
10. Eckardt KU. Anaemia in end-stage renal disease: Pathophysiological considerations. Nephrol Dial Transplant 2001; 16 [Suppl 7]: 2-8
11. Gurm HS, Lincoff AM, Kleiman NS et al. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. Am J Cardiol 2004; 94: 30-34
12. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295
13. Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 2003; 63: 696-701
14. World Health Organization. Nutritional anaemias: Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 33-37
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
16. Smith SC, Dove JT, Jacobs AK et al. ACC/AHA guidelines for percutaneous coronary interventions. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 3019-3041
17. Nikolsky E, Mehran R, Aymong ED et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 2004; 94: 1023-1027
18. Go AS, Yang J, Ackerson LM et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113: 2713-2723
19. Silverberg D, Wexler D, Blum M. The cardio-renal anaemia syndrome: Does it exist? Nephrol Dial Transplant 2003; 18 [Suppl 8]: Viii7-viii12
20. Silverberg DS, Wexler D, Iaina A. Anemia, chronic renal disease and congestive heart failure-the cardio renal anemia syndrome: The need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006; 38: 295-310
21. Eckardt KU. Cardiovascular risk reduction by early anemia treatment with epoetin beta. CREATE Trial. Nephrol Dial Transplant 2001; 16 [Suppl 2]: 16-18
22. Drueke TB, Locatelli F, Clyne N et al. CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
23. Singh AK, Szczech L, Tang KL et al. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
24. Namiuchi S, Kagaya Y, Ohta J. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 45: 1406-1412